DICOM GRID Recalls Ambra PACS Software Due to Image Display Error
DICOM GRID Inc. is recalling Ambra PACS software version V3.16.13.0 because a defect causes diagnostic images to appear washed out, potentially affecting image analysis.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a situation where use of the product may cause temporary or medically reversible adverse health consequences. The defect affects image quality (washed-out appearance) but no specific injuries or illnesses are reported in the source text, fitting the Moderate criteria for a software defect without reported harm.
Plain-English summary
DICOM GRID Inc. is recalling 209 units of Ambra PACS software, version V3.16.13.0, under FDA recall number Z-1045-2017. The software is intended for use as a primary diagnostic and analysis tool for diagnostic images.
The recall is due to a software error that causes the window and level settings to become identical across a series of images, regardless of the actual image levels. This defect results in the images having a washed-out grey appearance, which may compromise the diagnostic utility of the software.
The affected software was distributed in the United States to facilities in Texas, Florida, Nebraska, California, Wisconsin, Arizona, New Hampshire, Missouri, Massachusetts, Colorado, Pennsylvania, Nevada, Puerto Rico, Illinois, Ohio, New York, Maryland, New Jersey, Minnesota, Michigan, Connecticut, Virginia, Georgia, Utah, Kansas, Washington, and Hawaii. It was also distributed in Canada, Spain, Israel, Singapore, Kosovo, Austria, Brazil, Malaysia, and Australia. Users of this specific software version should contact DICOM GRID Inc. for further instructions regarding the recall.
The recalled product
- Product
- Ambra PACS UDI: +AMBRHEALTHSOLUTIONS0/$$+7_V3.16.13.0R Software Version Number: V3.16.13.0 Intended for use as a primary diagnostic and analysis tool for diagnostic images.
- Manufacturer
- DICOM GRID INC
- Category
- Medical Device — Software
- Affected units
- 209
Distribution
Related recalls
Same manufacturer · DICOM GRID INC
See all →- HighImaging viewer software recalled over inaccurate length measurement values
FDA (Devices) · 2025-12-24
Same hazard · software defect
See all →- ModerateBeckman Coulter Recalls DxC 500i Clinical Analyzer Modules Due to Software Error
FDA (Devices) · 2026-10-14
- HighPhilips Spectral CT Systems Recalled for Software Issues Affecting Safety
FDA (Devices) · 2026-10-14
- ModerateSteris HexaVue Focus Integration System Recalled for Patient Data Mismatch
FDA (Devices) · 2026-10-14
- ModerateUnited Imaging uCT 760 CT System Recalled for Software Visibility Issue
FDA (Devices) · 2026-10-07
- ModerateUnited Imaging uCT 550 CT Systems Recalled for Software Defect
FDA (Devices) · 2026-10-07
Similar recalls
- HighDiagnostic imaging software may lose patient information edits during processing
FDA (Devices) · 2022-10-05
- HighHitachi VidiStar PACS Software Recalled for Potential Image Mix-Up
FDA (Devices) · 2018-09-12
- HighAgfa Healthcare Recalls NX 3.0.8950 Imaging Processing Software
FDA (Devices) · 2017-07-26
- HighMerge Healthcare Recalls Unity PACS Software Due to Image Error
FDA (Devices) · 2017-03-08
- HighSynapse PACS medical imaging software version 7.1.000 recalled for measurement error
FDA (Devices) · 2024-03-13
- HighSiemens Syngo.plaza PACS Software Recalled for Data Security and Integrity Issues
FDA (Devices) · 2018-02-07